01 November 2010
By Teena Thacker
New Delhi, India
Anesthetic drug Ketamine will no longer be available ‘over the counter’ in India and can be obtained only with a prescription in duplicate. Chemists will have to retain the duplicate prescription for two years.
In a drug consultative committee meeting last week, the Drug Controller General of India (DCGI) shifted Ketamine from Schedule H to Schedule X, for which special control measures will have to be taken.
The decision was taken following complaints of its misuse.
"India has become a major Ketamine source for South East Asian countries. The shifting of Ketamine from H to X will help bring this down," said Dr Surinder Singh, DCGI.
Shifting Ketamine would mean an extensive documentation for chemists, including two sets of prescription. Chemists would need a licence from the State Food and Drug Administration to sell it or face punishment.
Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.
